Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer

Abstract Human epidermal growth factor receptor 2 (HER2) gene amplification in circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) might be useful for modifying Herceptin therapy in breast cancer. In the process of investigating the utility of a microfluidic platform for detecting HER...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Savitri Krishnamurthy, Farideh Bischoff, Julie Ann Mayer, Karina Wong, Tam Pham, Henry Kuerer, Ashutosh Lodhi, Anirban Bhattacharyya, Carolyn Hall, Anthony Lucci
Format:	Article
Language:	English
Published:	Wiley 2013-04-01
Subjects:	Breast cancer circulating tumor cells disseminated tumor cells HER2 status minimal residual disease
Online Access:	https://doi.org/10.1002/cam4.70